Skip to main content

Metalyse 8,000 units (40 mg) injectable

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Contents of the leaflet

  1. Introduction
  2. What Metalyse is and what it is used for
  3. What you need to know before you are given Metalyse
  4. How Metalyse is given
  5. Possible side effects
  6. Storage of Metalyse
  7. Contents of the pack and other information

Introduction

Package Leaflet: Information for the User

Metalyse 8,000 units (40 mg) powder and solvent for solution for injection

Metalyse 10,000 units (50 mg) powder and solvent for solution for injection

tenecteplase

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Metalyse is and what it is used for
  2. What you need to know before you are given Metalyse
  3. How Metalyse is given
  4. Possible side effects
  5. Storage of Metalyse
  6. Contents of the pack and other information

1. What Metalyse is and what it is used for

Metalyse is a powder and solvent for solution for injection.

Metalyse belongs to a group of medicines called thrombolytics. These medicines help to dissolve blood clots. Tenecteplase is a recombinant fibrin-specific plasminogen activator.

Metalyse is used to treat heart attacks (myocardial infarction) within 6 hours of the start of symptoms and helps to dissolve blood clots that have formed in the heart's blood vessels. This helps to prevent damage caused by heart attacks and has been shown to save lives.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Metalyse

Metalyse will not be prescribed or given to you by your doctor

  • if you have previously had a severe allergic reaction (hypersensitivity) to tenecteplase, to any of the other ingredients of this medicine (listed in section 6) or to gentamicin (a residual substance from the manufacturing process). If treatment with Metalyse is still considered necessary, resuscitation equipment must be available for immediate use if needed;
  • if you have, or have recently had, a condition that increases your risk of bleeding (haemorrhage), including:
  • a bleeding disorder or tendency to bleed
  • stroke (cerebrovascular accident)
  • very high blood pressure, not controlled
  • a head injury
  • severe liver disease
  • a stomach ulcer (peptic ulcer)
  • varices in the oesophagus (oesophageal varices)
  • blood vessel abnormalities (e.g. an aneurysm)
  • certain tumours
  • inflammation of the heart lining (pericarditis); inflammation or infection of the heart valves (endocarditis)
  • dementia;
  • if you are taking tablets/capsules to "thin" the blood, such as warfarin (anticoagulants);
  • if you have pancreatitis (inflammation of the pancreas);
  • if you have recently had major surgery, including brain or spinal surgery;
  • if you have had cardiopulmonary resuscitation (chest compressions) for more than 2 minutes in the last 2 weeks.

Warnings and precautions

Your doctor will take special care with Metalyse

  • if you have had any allergic reaction other than a severe allergic reaction (hypersensitivity) to tenecteplase, to any of the other ingredients of this medicine (listed in section 6) or to gentamicin (a residual substance from the manufacturing process);
  • if you have high blood pressure;
  • if you have problems with blood circulation in the brain (cerebrovascular disease);
  • if you have had bleeding in the gut or urinary tract in the last 10 days (this could cause blood to appear in your stools or urine);
  • if you have a heart valve abnormality (e.g. mitral stenosis) with an irregular heartbeat (e.g. atrial fibrillation);
  • if you have had an intramuscular injection in the last 2 days;
  • if you are over 75 years old;
  • if you weigh less than 60 kg;
  • if you have been given Metalyse before.

Children and adolescents

Metalyse is not recommended for use in children and adolescents under 18 years.

Other medicines and Metalyse

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before you are given this medicine.

3. How Metalyse is given

Your doctor will calculate your dose of Metalyse according to your body weight, as follows:

Body weight (kg)

Less than 60

60 to 70

70 to 80

80 to 90

Over 90

Metalyse (U)

6,000

7,000

8,000

9,000

10,000

Your doctor will give you a medicine to prevent blood clotting, in addition to Metalyse, as soon as possible after your chest pain starts.

Metalyse is given as a single injection into a vein by a doctor with experience in the use of this type of medicine.

Your doctor will give you Metalyse as soon as possible after the start of your chest pain, as a single dose.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been experienced by patients given Metalyse:

Very common (may affect more than 1 in 10 people):

  • bleeding

Common (may affect up to 1 in 10 people):

  • bleeding at the injection or puncture site
  • nosebleeds
  • genitourinary bleeding (you may see blood in your urine)
  • bruising
  • gastrointestinal bleeding (e.g. bleeding from the stomach or intestines)

Uncommon (may affect up to 1 in 100 people):

  • irregular heartbeats (reperfusion arrhythmias), which occasionally lead to cardiac arrest. Cardiac arrest can be life-threatening.
  • internal bleeding in the abdomen (retroperitoneal bleeding)
  • bleeding in the brain (cerebral bleeding). After a brain bleed or other serious bleeding events, death or permanent disability can occur.
  • bleeding in the eyes (ocular bleeding)

Frequency not known (cannot be estimated from the available data):

  • low blood pressure (hypotension)
  • bleeding in the lungs (pulmonary bleeding)
  • allergic reactions (anaphylactoid reactions), e.g. rash, hives, difficulty breathing (bronchospasm)
  • bleeding in the area surrounding the heart (haemopericardium)
  • blood clots in the lungs (pulmonary embolism) and in the blood vessels of other organ systems (thrombotic embolisms)

Frequency not known (cannot be estimated from the available data):

  • fat embolism (clots formed by fat)
  • nausea
  • vomiting
  • increased body temperature (fever)
  • blood transfusions as a result of bleeding

As with other thrombolytic agents, the following events have been reported as a consequence of myocardial infarction and/or thrombolytic administration:

Very common (may affect more than 1 in 10 people):

  • low blood pressure (hypotension)
  • irregular heartbeats
  • chest pain (angina)

Common (may affect up to 1 in 10 people):

  • additional chest pain/angina (recurrent ischaemia)
  • heart attack
  • heart failure
  • shock due to heart failure
  • inflammation of the heart lining
  • fluid in the lungs (pulmonary oedema)

Uncommon (may affect up to 1 in 100 people):

  • cardiac arrest
  • problems with the heart valve or heart lining (mitral regurgitation, pericardial effusion)
  • blood clots in the veins (venous thrombosis)
  • fluid between the heart lining and the heart (cardiac tamponade)
  • rupture of the heart muscle (myocardial rupture)

Rare (may affect up to 1 in 1,000 people):

  • blood clots in the lungs (pulmonary embolism)

These cardiovascular events can be life-threatening and may lead to death.

In the case of brain bleeding, effects related to the nervous system have been reported, e.g. drowsiness, speech disorders, paralysis of parts of the body (hemiparesis) and convulsions.

Reporting of side effects

If you experience any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Metalyse

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP.

Do not store above 30°C.

Store the pack in the outer carton to protect from light.

After reconstitution, Metalyse can be stored for 24 hours at 2-8°C and 8 hours at 30°C. However, for microbiological reasons, your doctor will normally use the reconstituted solution immediately.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Contents of the pack and other information

What Metalyse contains

  • The active substance is tenecteplase.
  • Each vial contains 8,000 units (40 mg) of tenecteplase. Each pre-filled syringe contains 8 ml of solvent. Each ml contains 1,000 units of tenecteplase when reconstituted with 8 ml of solvent.

or

  • Each vial contains 10,000 units (50 mg) of tenecteplase. Each pre-filled syringe contains 10 ml of solvent. Each ml contains 1,000 units of tenecteplase when reconstituted with 10 ml of solvent.
  • The other ingredients are arginine, phosphoric acid, and polysorbate 20.
  • The solvent is water for injections.
  • It contains gentamicin as a residual substance from the manufacturing process.

Appearance and pack contents

The pack contains:

  • a vial with 40 mg of tenecteplase as a lyophilised powder, a pre-filled syringe with 8 ml of solvent, and a vial adapter.

or

  • a vial with 50 mg of tenecteplase as a lyophilised powder, a pre-filled syringe with 10 ml of solvent, and a vial adapter.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

Boehringer Ingelheim International GmbH

Binger Strasse 173

55216 Ingelheim am Rhein

Germany

Manufacturer

Boehringer Ingelheim Pharma GmbH & Co. KG

Birkendorfer Strasse 65

88397 Biberach/Riss

Germany

Boehringer Ingelheim France

100-104 avenue de France

75013 Paris

France

You can get more information about this medicine by contacting the local representative of the marketing authorisation holder:

België/Belgique/Belgien

Lietuva

Boehringer Ingelheim SComm

Boehringer Ingelheim RCV GmbH & Co KG

Tél/Tel: +32 2 773 33 11

Lietuvos filialas

Tel: +370 5 2595942

България

Luxembourg/Luxemburg

Бохрингер Ингелхайм България ЕООД

Boehringer Ingelheim SComm

Tél/Tel: +32 2 773 33 11

Tел: +359 2 958 79 98

Ceská republika

Magyarország

Boehringer Ingelheim spol. s r.o.

Boehringer Ingelheim RCV GmbH & Co KG

Magyarországi Fióktelepe

Tel: +420 234 655 111

Tel: +36 1 299 89 00

Danmark

Malta

Boehringer Ingelheim Danmark A/S

Boehringer Ingelheim Ireland Ltd.

Tlf: +45 39 15 88 88

Tel: +353 1 295 9620

Deutschland

Nederland

Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim B.V.

Tel: +49 (0) 800 77 90 900

Tel: +31 (0) 800 22 55 889

Eesti

Norge

Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal

Boehringer Ingelheim Norway KS

Tel: +372 612 8000

Tlf: +47 66 76 13 00

Ελλάδα

Österreich

Boehringer Ingelheim Ελλάς Μονοπρόσωπη Α.Ε.

Boehringer Ingelheim RCV GmbH & Co KG

Τηλ: +30 2 10 89 06 300

Tel: +43 1 80 105-7870

España

Polska

Boehringer Ingelheim España, S.A.

Boehringer Ingelheim Sp. z o.o.

Tel: +34 93 404 51 00

Tel: +48 22 699 0 699

France

Portugal

Boehringer Ingelheim France S.A.S.

Boehringer Ingelheim Portugal, Lda.

Tél: +33 3 26 50 45 33

Tel: +351 21 313 53 00

Hrvatska

România

Boehringer Ingelheim Zagreb d.o.o.

Boehringer Ingelheim RCV GmbH & Co KG

Tel: +385 1 2444 600

Viena - Sucursala Bucuresti

Tel: +40 21 302 28 00

Ireland

Slovenija

Boehringer Ingelheim Ireland Ltd.

Boehringer Ingelheim RCV GmbH & Co KG

Tel: +353 1 295 9620

Podružnica Ljubljana

Tel: +386 1 586 40 00

Ísland

Slovenská republika

Vistor hf.

Boehringer Ingelheim RCV GmbH & Co KG

Sími: +354 535 7000

organizacná zložka

Tel: +421 2 5810 1211

Italia

Suomi/Finland

Boehringer Ingelheim Italia S.p.A.

Boehringer Ingelheim Finland Ky

Tel: +39 02 5355 1

Puh/Tel: +358 10 3102 800

Κύπρος

Sverige

Boehringer Ingelheim Ελλάς Μονοπρόσωπη Α.Ε.

Boehringer Ingelheim AB

Τηλ: +30 2 10 89 06 300

Tel: +46 8 721 21 00

Latvija

United Kingdom (Northern Ireland)

Boehringer Ingelheim RCV GmbH & Co KG

Boehringer Ingelheim Ireland Ltd.

Latvijas filiale

Tel: +353 1 295 9620

Tel: +371 67 240 011

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/.

The leaflet can be found in all EU/EEA languages on the European Medicines Agency website.

Online doctors for METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Discuss questions about METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION is tenecteplase. This information helps identify medicines with the same composition but different brand names.

METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION is manufactured by Boehringer Ingelheim International Gmbh. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Cardiologists, Nephrologists, Hematologists, General surgeons, General medicine doctors, Phlebologists may assess whether METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, METALYSE 8,000 UNITS (40 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (tenecteplase) include METALYSE 10,000 UNITS (50 MG) POWDER AND SOLVENT FOR INJECTABLE SOLUTION, METALYSE 5,000 UNITS (25 MG) POWDER FOR INJECTABLE SOLUTION, ACTILYSE powder and solvent for injectable solution and for infusion. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media